Zhongqi Capital

Private Equity China

Overview

Zhongqi Capital is a Chinese private equity firm investing in growth-stage companies across multiple sectors. The firm focuses on sectors such as biotechnology, healthcare, medical, advanced materials, oil and gas, sensor, industrial manufacturing, and laser technologies. Zhongqi Capital has a track record of leading investments in early-stage ventures, with an average round size of $3 million, and has been active in the Chinese market since at least 2023.

Investment Focus

  • Growth-stage companies in China

Portfolio Companies

Rona TherapeuticsDeptrumGuiyan ElectronicDelova BiotechSinoma High-tech MaterialsBioyiFudou New MaterialsLance TechnologyAowei Technology

Reach Zhongqi Capital directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Zhongqi Capital

What sectors does Zhongqi Capital invest in?

Zhongqi Capital invests in Healthcare, Industrial Manufacturing, Biotechnology, Oil and Gas, Medical and Advanced Materials, and is based in China. Zhongqi Capital is listed as a private equity in the ConnectSafely investor database.

What stage does Zhongqi Capital invest at?

Zhongqi Capital backs companies at Early Stage, Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 3M - 3M.

Which regions does Zhongqi Capital invest in?

Zhongqi Capital invests across China.

What companies has Zhongqi Capital invested in?

Zhongqi Capital's portfolio includes Rona Therapeutics, Deptrum, Guiyan Electronic, Delova Biotech, Sinoma High-tech Materials, Bioyi, Fudou New Materials and Lance Technology.

Last updated · Source: ConnectSafely investor database